These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 18092947

  • 1. The lectin-like oxidized low-density-lipoprotein receptor: a pro-inflammatory factor in vascular disease.
    Dunn S, Vohra RS, Murphy JE, Homer-Vanniasinkam S, Walker JH, Ponnambalam S.
    Biochem J; 2008 Jan 15; 409(2):349-55. PubMed ID: 18092947
    [Abstract] [Full Text] [Related]

  • 2. Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.
    Reiss AB, Anwar K, Wirkowski P.
    Curr Med Chem; 2009 Jan 15; 16(21):2641-52. PubMed ID: 19601801
    [Abstract] [Full Text] [Related]

  • 3. LOX-1 receptor: A potential link in atherosclerosis and cancer.
    Balzan S, Lubrano V.
    Life Sci; 2018 Apr 01; 198():79-86. PubMed ID: 29462603
    [Abstract] [Full Text] [Related]

  • 4. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease.
    Akhmedov A, Sawamura T, Chen CH, Kraler S, Vdovenko D, Lüscher TF.
    Eur Heart J; 2021 May 07; 42(18):1797-1807. PubMed ID: 36282110
    [Abstract] [Full Text] [Related]

  • 5. Lectin-like Oxidized Low-Density Lipoprotein (LDL) Receptor (LOX-1): A Chameleon Receptor for Oxidized LDL.
    Zeya B, Arjuman A, Chandra NC.
    Biochemistry; 2016 Aug 16; 55(32):4437-44. PubMed ID: 27419271
    [Abstract] [Full Text] [Related]

  • 6. LOX-1 and obesity.
    Yan M, Mehta JL, Hu C.
    Cardiovasc Drugs Ther; 2011 Oct 16; 25(5):469-76. PubMed ID: 21881850
    [Abstract] [Full Text] [Related]

  • 7. Role of Ox-LDL/LOX-1/NF-κB signaling pathway in regulation of atherosclerotic plaque growth by testosterone in male rabbits.
    Li S, Guo Y, Zhu P, Yang T.
    Vascul Pharmacol; 2013 Oct 16; 59(5-6):131-7. PubMed ID: 23022624
    [Abstract] [Full Text] [Related]

  • 8. Atherosclerosis and the Lectin-like OXidized low-density lipoprotein scavenger receptor.
    Vohra RS, Murphy JE, Walker JH, Ponnambalam S, Homer-Vanniasinkam S.
    Trends Cardiovasc Med; 2006 Feb 16; 16(2):60-4. PubMed ID: 16473764
    [Abstract] [Full Text] [Related]

  • 9. LOX-1, OxLDL, and atherosclerosis.
    Pirillo A, Norata GD, Catapano AL.
    Mediators Inflamm; 2013 Feb 16; 2013():152786. PubMed ID: 23935243
    [Abstract] [Full Text] [Related]

  • 10. Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1.
    Cimmino G, Cirillo P, Conte S, Pellegrino G, Barra G, Maresca L, Morello A, Calì G, Loffredo F, De Palma R, Arena G, Sawamura T, Ambrosio G, Golino P.
    Cardiovasc Res; 2020 May 01; 116(6):1125-1135. PubMed ID: 31504248
    [Abstract] [Full Text] [Related]

  • 11. Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1): a crucial driver of atherosclerotic cardiovascular disease.
    Akhmedov A, Sawamura T, Chen CH, Kraler S, Vdovenko D, Lüscher TF.
    Eur Heart J; 2021 May 07; 42(18):1797-1807. PubMed ID: 33159784
    [Abstract] [Full Text] [Related]

  • 12. Effect of IL-10 on LOX-1 expression, signalling and functional activity: an atheroprotective response.
    Arjuman A, Chandra NC.
    Diab Vasc Dis Res; 2013 Sep 07; 10(5):442-51. PubMed ID: 23811604
    [Abstract] [Full Text] [Related]

  • 13. Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.
    Singh S, Gautam AS.
    Curr Atheroscler Rep; 2019 Jul 27; 21(10):38. PubMed ID: 31350594
    [Abstract] [Full Text] [Related]

  • 14. Role of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Inflammation and Pathogen-Associated Interactions.
    Truthe S, Klassert TE, Schmelz S, Jonigk D, Blankenfeldt W, Slevogt H.
    J Innate Immun; 2024 Jul 27; 16(1):105-132. PubMed ID: 38232720
    [Abstract] [Full Text] [Related]

  • 15. The role of LOX-1, a novel lectin-like receptor for oxidized low density lipoprotein, in atherosclerosis.
    Mehta JL.
    Can J Cardiol; 2004 Aug 27; 20 Suppl B():32B-36B. PubMed ID: 15309203
    [Abstract] [Full Text] [Related]

  • 16. LOX-1-Mediated Effects on Vascular Cells in Atherosclerosis.
    Chistiakov DA, Orekhov AN, Bobryshev YV.
    Cell Physiol Biochem; 2016 Aug 27; 38(5):1851-9. PubMed ID: 27160316
    [Abstract] [Full Text] [Related]

  • 17. The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation.
    Wang Z, Chen J, Zeng Z, Zhang Q, Du G, Guo X, Wei Y.
    Mol Med; 2022 Mar 02; 28(1):26. PubMed ID: 35236285
    [Abstract] [Full Text] [Related]

  • 18. Impact of plasma oxidized low-density lipoprotein removal on atherosclerosis.
    Ishigaki Y, Katagiri H, Gao J, Yamada T, Imai J, Uno K, Hasegawa Y, Kaneko K, Ogihara T, Ishihara H, Sato Y, Takikawa K, Nishimichi N, Matsuda H, Sawamura T, Oka Y.
    Circulation; 2008 Jul 01; 118(1):75-83. PubMed ID: 18559699
    [Abstract] [Full Text] [Related]

  • 19. Oxidized LDL, LOX-1 and atherosclerosis.
    Mitra S, Goyal T, Mehta JL.
    Cardiovasc Drugs Ther; 2011 Oct 01; 25(5):419-29. PubMed ID: 21947818
    [Abstract] [Full Text] [Related]

  • 20. LOX-1 and atherosclerotic-related diseases.
    Jin P, Cong S.
    Clin Chim Acta; 2019 Apr 01; 491():24-29. PubMed ID: 30639239
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.